Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05005078 · ClinicalTrials.gov registry record · Phase 2
A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV
A Phase 2 study, sponsored by WinSanTor.
- Completed
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT05005078 is a Phase 2 study that has completed, run by WinSanTor. The registered enrollment target is 16 participants.
The verdict
NCT05005078, a Phase 2 study, has completed, sponsored by WinSanTor.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is a two-part study of the safety, tolerability, and efficacy of topically administered WST-057 for 16 weeks in subjects with HIV with sensory polyneuropathy.
Interventions
- DRUG Placebo
- DRUG WST-057
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-02-24 |
| Est. Completion | 2023-01-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05005078
The ClinicalTrials.gov registry entry for NCT05005078 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is WinSanTor, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05005078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05005078 about?
NCT05005078 is a clinical study titled "A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV". This is a two-part study of the safety, tolerability, and efficacy of topically administered WST-057 for 16 weeks in subjects with HIV with sensory polyneuropathy.
What is the current status of trial NCT05005078?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2022-02-24. Estimated completion is 2023-01-24.
What interventions are being tested in trial NCT05005078?
The interventions under investigation include: Placebo (DRUG), WST-057 (DRUG).
Who is sponsoring clinical trial NCT05005078?
This trial is sponsored by WinSanTor, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.